v3.22.1
Consolidated Statements Of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash Flows from Operating Activities:    
Net loss $ (4,776) $ (6,901)
Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities:    
Depreciation and amortization 117 85
Provision for bad debts 84 (106)
Provision for sales returns 60 90
Inventory write-offs and disposals 0 (20)
Amortization of discounts on lines of credit 24 42
Amortization of debt issuance costs 43 95
Patent litigation mark-to-market 0 89
Stock-based compensation 209 928
Changes in operating assets and liabilities:    
Accounts receivable (1,085) (193)
Inventory (1,682) (700)
Prepaid expenses and other current assets (186) 558
Accounts payable and accrued liabilities (986) (488)
Deferred revenue 157 22
Net cash and cash equivalents used in operating activities (8,021) (6,499)
Cash Flows from Investing Activities:    
Purchases of property, plant, and equipment (304) (8)
Net cash and cash equivalents used in investing activities (304) (8)
Cash Flows from Financing Activities:    
Proceeds from the issuance of common stock, net of offering costs 0 13,292
Payments of equity offering costs 0 (6)
Proceeds from the exercise of common stock warrants 0 16,539
Net cash and cash equivalents provided by financing activities 0 29,825
Effect of exchange rate changes (41) (148)
(Decrease) increase in cash, cash equivalents and restricted cash (8,366) 23,170
Cash, cash equivalents and restricted cash, beginning of period 30,175 17,876
Cash, cash equivalents and restricted cash, end of period 21,809 41,046
Supplemental cash flow disclosure:    
Cash paid for interest 377 448
Cash received for interest 10 14
Cash paid for income taxes 26 10
Cash paid for operating leases 66 66
Non-cash settlement of liability 0 510
Non-cash right-of-use assets obtained in exchange for lease obligation 444 0
Deemed dividend on preferred stock $ 217 $ 532

Source